Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Synthesis of purine and 7-deazapurine nucleoside analogues of 6-N-(4-Nitrobenzyl)adenosine; inhibition of nucleoside transport and proliferation of cancer cells.

Rayala R, Theard P, Ortiz H, Yao S, Young JD, Balzarini J, Robins MJ, Wnuk SF.

ChemMedChem. 2014 Sep;9(9):2186-92. doi: 10.1002/cmdc.201402047. Epub 2014 Apr 30.

PMID:
24788480
[PubMed - in process]
2.

A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.

SenGupta DJ, Lum PY, Lai Y, Shubochkina E, Bakken AH, Schneider G, Unadkat JD.

Biochemistry. 2002 Feb 5;41(5):1512-9.

PMID:
11814344
[PubMed - indexed for MEDLINE]
3.
4.

Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.

Gupta PK, Daunert S, Nassiri MR, Wotring LL, Drach JC, Townsend LB.

J Med Chem. 1989 Feb;32(2):402-8.

PMID:
2913300
[PubMed - indexed for MEDLINE]
8.

Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.

Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, Cass CE.

Neuropharmacology. 2001 Apr;40(5):722-31.

PMID:
11311901
[PubMed - indexed for MEDLINE]
9.

Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.

Sundaram M, Yao SY, Ng AM, Griffiths M, Cass CE, Baldwin SA, Young JD.

J Biol Chem. 1998 Aug 21;273(34):21519-25.

PMID:
9705281
[PubMed - indexed for MEDLINE]
Free Article
10.

Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).

Yao SY, Ng AM, Cass CE, Baldwin SA, Young JD.

J Biol Chem. 2011 Sep 16;286(37):32552-62. doi: 10.1074/jbc.M111.236117. Epub 2011 Jul 27.

PMID:
21795683
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.

Chang C, Swaan PW, Ngo LY, Lum PY, Patil SD, Unadkat JD.

Mol Pharmacol. 2004 Mar;65(3):558-70.

PMID:
14978234
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.

Hummel-Eisenbeiss J, Hascher A, Hals PA, Sandvold ML, Müller-Tidow C, Lyko F, Rius M.

Mol Pharmacol. 2013 Sep;84(3):438-50. doi: 10.1124/mol.113.086801. Epub 2013 Jun 28.

PMID:
23814180
[PubMed - indexed for MEDLINE]
Free Article
14.
16.

Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281.

Hughes SJ, Cravetchi X, Vilas G, Hammond JR.

Cell Signal. 2015 Feb 25. pii: S0898-6568(15)00069-8. doi: 10.1016/j.cellsig.2015.02.023. [Epub ahead of print]

PMID:
25725289
[PubMed - as supplied by publisher]
17.
18.
19.

Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.

Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, Baldwin SA.

Biochem J. 1997 Dec 15;328 ( Pt 3):739-43.

PMID:
9396714
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.

Aguayo C, Casado J, González M, Pearson JD, Martín RS, Casanello P, Pastor-Anglada M, Sobrevia L.

Placenta. 2005 Sep-Oct;26(8-9):641-53. Epub 2004 Dec 15.

PMID:
16085043
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk